Warner L E, Shohat M, Shorer Z, Lupski J R
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
Hum Mutat. 1997;10(1):21-4. doi: 10.1002/(SICI)1098-1004(1997)10:1<21::AID-HUMU3>3.0.CO;2-P.
Dejerine-Sottas syndrome (DSS), a severe demyelinating peripheral neuropathy with onset in infancy, has been associated with mutations in either PMP22 or MPZ. Most cases of DSS are caused by a single heterozygous dominant point mutation. We identified three de novo point mutations in MPZ exon 3 in a sporadic DSS patient. These three point mutations occur on the same allele and result in three novel amino acid substitutions: Ile(85)Thr, Asn(87)His, and Asp(99)Asn. Our data raise the question as to the potential mechanism(s) involved in the formation of multiple point mutations at a given locus.
德热里纳 - 索塔斯综合征(DSS)是一种严重的脱髓鞘性周围神经病,起病于婴儿期,与PMP22或MPZ的突变有关。大多数DSS病例由单个杂合显性点突变引起。我们在一名散发性DSS患者的MPZ外显子3中鉴定出三个新发点突变。这三个点突变发生在同一等位基因上,导致三个新的氨基酸替换:Ile(85)Thr、Asn(87)His和Asp(99)Asn。我们的数据提出了关于在给定基因座形成多个点突变所涉及的潜在机制的问题。